Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 162-168

  Price, M A ^a   Bell, M L ^a   Sommeijer, D W ^a   Friedlander, M ^a,b   Stockler, M R ^a,c   Defazio, A ^a   Webb, P M ^d   Butow, P N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Coping; End of life; Ovarian cancer; Psychosocial; Quality of life; Symptoms

Indexed keywords

ABDOMINAL SWELLING; ADULT; AGED; ANOREXIA; ARTICLE; CANCER MORTALITY; CANCER PAIN; CANCER PATIENT; COHORT ANALYSIS; COPING BEHAVIOR; DISEASE SEVERITY; ENERGY; FEMALE; HELPLESSNESS; HOPELESSNESS; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; NAUSEA; OPTIMISM; OVARY CANCER; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RECURRENT CANCER; SYMPTOM; TERMINAL CARE;

ADAPTATION, PSYCHOLOGICAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84879120613     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.031     Document Type: Article

References (43)

1. M.P. Coleman, D. Forman, H. Bryant, J. Butler, B. Rachet, and C. Maringe Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 9760 2011 127 138
2. V. von Gruenigen, H.E. Frasure, A.M. Reidy, and K.M. Gil Clinical disease course during the last year in ovarian cancer Gynecol Oncol 90 3 2003 619 624
3. L.J. Herrinton, C. Neslund-Dudas, S.J. Rolnick, M.C. Hornbrook, D.J. Bachman, and J.A. Darbinian Complications at the end of life in ovarian cancer J Pain Symptom Manage 34 3 2007 237 243
4. J.M. Giesinger, L.M. Wintner, A.S. Oberguggenberger, E.M. Gamper, M. Fiegl, and H. Denz Quality of life trajectory in patients with advanced cancer during the last year of life J Palliat Med 14 8 2011 904 912
5. S.S. Hwang, V.T. Chang, D.L. Fairclough, J. Cogswell, and B. Kasimis Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center J Pain Symptom Manage 25 3 2003 225 235
6. B. Ferrell, C.A. Cullinane, K. Ervine, C. Melancon, G.C. Uman, and G. Juarez Perspectives on the impact of ovarian cancer: women's views of quality of life Oncol Nurs Forum 32 6 2005 1143 1149
7. H.W. van Laarhoven, J. Schilderman, G. Bleijenberg, R. Donders, K.C. Vissers, and C.A. Verhagen Coping, quality of life, depression, and hopelessness in cancer patients in a curative and palliative, end-of-life care setting Cancer Nurs 34 4 2011 302 314
8. S.K. Lutgendorf, B. Anderson, P. Ullrich, E.L. Johnsen, R.E. Buller, and A.K. Sood Quality of life and mood in women with gynecologic cancer: a one year prospective study Cancer 94 1 2002 131 140
9. J. Brown, R.F. Brown, R.M. Miller, S.M. Dunn, M.T. King, and A.S. Coates Coping with metastatic melanoma: the last year of life Psychooncology 9 4 2000 283 292
10. P. Butow, A.S. Coates, and S.M. Dunn Psychosocial predictors of survival: metastatic breast cancer Ann Oncol 11 4 2000 469 474
11. S.K. Lutgendorf, K. De Geest, D. Bender, A. Ahmed, M.J. Goodheart, and L. Dahmoush Social influences on clinical outcomes of patients with ovarian cancer J Clin Oncol 30 23 2012 2885 2890
12. S.J. Jordan, A.C. Green, D.C. Whiteman, S.P. Moore, C.J. Bain, and D.G. Gertig Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis Int J Cancer 122 2008 1598 1603
13. M.A. Price, R. Zachariae, P.N. Butow, A. deFazio, D. Chauhan, and C.A. Espie Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor Eur J Cancer 45 18 2009 3262 3270
14. M.A. Price, P.N. Butow, D.S. Costa, M.T. King, L.A. Aldridge, and J. Fardell Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers Med J Aust 193 5 2010 S52 S57
15. K. Basen-Engquist, D. Bodurka-Bevers, M.A. Fitzgerald, K. Webster, D. Cella, and S. Hu Reliability and validity of the functional assessment of cancer therapy-ovarian J Clin Oncol 19 6 2001 1809 1817
16. M.T. King, M.R. Stockler, D.F. Cella, D. Osoba, D.T. Eton, and J. Thompson Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G J Clin Epidemiol 63 3 2010 270 281
17. W.E. Broadhead, S.H. Gehbach, F.V. de Gruy, and B.H. Kaplan The Duke-UNC Functional Social Support Questionnaire Med Care 26 7 1988 709 723
18. M.F. Scheier, C.S. Carver, and M.W. Bridges Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test J Pers Soc Psychol 67 6 1994 1063 1078
19. M. Watson, S. Greer, J. Young, Q. Inayat, C. Burgess, and B. Robertson Development of a questionnaire measure of adjustment to cancer: the MAC scale Psychol Med 18 1 1988 203 209
20. R.H. Osborne, G.R. Elsworth, D.W. Kissane, S.A. Burke, and J.L. Hopper The Mental Adjustment to Cancer (MAC) scale: replication and refinement in 632 breast cancer patients Psychol Med 29 6 1999 1335 1345
21. G.M. Fitzmaurice, N.M. Laird, and J.H. Ware Applied Longitudinal Analysis 2011 Wiley Hoboken NJ
22. S. Beijer, G.I. Kempen, M.C. Pijls-Johannesma, A. de Graeff, and P.C. Dagnelie Determinants of overall quality of life in preterminal cancer patients Int J Cancer 123 1 2008 232 235
23. O. Minton, A. Richardson, M. Sharpe, M. Hotopf, and P. Stone Drug therapy for the management of cancer-related fatigue Cochrane Database Syst Rev 7 2010 CD006704
24. National Comprehensive Cancer Network Cancer Related Fatigue NCCN clinical practice guidelines in oncology 2012
25. Y. Malayev, R. Levene, and F. Gonzalez Palliative chemotherapy for malignant ascites secondary to ovarian cancer Am J Hosp Palliat Care 29 7 2012 515 521
26. M.M. Heiss, P. Murawa, P. Koralewski, E. Kutarska, O.O. Kolesnik, and V.V. Ivanchenko The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial Int J Cancer 127 9 2010 2209 2221
27. C.A. Hamilton, G.L. Maxwell, M.R. Chernofsky, S.A. Bernstein, J.H. Farley, and G.S. Rose Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer Gynecol Oncol 111 3 2008 530 532
28. W.H. Gotlieb, F. Amant, S. Advani, C. Goswami, H. Hirte, and D. Provencher Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study Lancet Oncol 13 2 2012 154 162
29. N. Colombo, G. Mangili, S. Mammoliti, M. Kalling, B. Tholander, and L. Sternas A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites Gynecol Oncol 125 1 2012 42 47
30. D. Walsh, S. Donnelly, and L. Rybicki The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients Support Care Cancer 8 3 2000 175 179
31. A.S. Strömgren, P. Sjogren, D. Goldschmidt, M.A. Petersen, L. Pedersen, and M. Groenvold Symptom priority and course of symptomatology in specialized palliative care J Pain Symptom Manage 31 3 2006 199 206
32. S.J. Rolnick, J. Jackson, W.W. Nelson, A. Butani, L.J. Herrinton, and M. Hornbrook Pain management in the last six months of life among women who died of ovarian cancer J Pain Symptom Manage 33 1 2007 24 31
33. D. Thapa, V. Rastogi, and V. Ahuja Cancer pain management-current status J Anaesthesiol Clin Pharmacol 27 2 2011 162 168
34. C.I. Ripamonti, E. Bandieri, and F. Roila Management of cancer pain: ESMO Clinical Practice Guidelines Ann Oncol 22 Suppl. 6 2011 vi69 vi77
35. A. Montazeri Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008 Health Qual Life Outcomes 23 7 2009 102 10.1186/1477-7525-7-102
36. M.S. Carey, M. Bacon, D. Tu, L. Butler, A. Bezjak, and G.C. Stuart The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer Gynecol Oncol 108 1 2008 100 105
37. M. Friedlander, P. Butow, M. Stockler, C. Gainford, J. Martyn, and A. Oza Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer Int J Gynecol Cancer Suppl. 2 2009 S44 S48
38. J.M. Clayton, K.M. Hancock, P.B. Butow, M.H.N. Tattersall, D.C. Currow, and Australian and New Zealand Expert Advisory Group Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers Med J Aust 186 12 Suppl. 2007 S77 S108
39. M.S. Vos, H. Putter, H.C. van Houwelingen, and H.C. de Haes Denial and physical outcomes in lung cancer patients, a longitudinal study Lung Cancer 67 2 2010 237 243
40. M.S. Vos, H. Putter, H.C. van Houwelingen, and H.C. de Haes Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial Lung Cancer 72 1 2011 119 124
41. E. Foley, A. Baillie, M. Huxter, M.A. Price, and E. Sinclair Mindfulness Based Cognitive Therapy for Individuals whose lives have been affected by cancer: A randomized controlled trial J Consult Clin Psychol 78 1 2010 72 79
42. C. Shennan, S. Payne, and D. Fenlon What is the evidence for the use of mindfulness-based interventions in cancer care? A review Psychooncology 20 7 2011 681 697
43. A.D. Rost, K. Wilson, E. Buchanan, M.J. Hildebrandt, and D. Mutch Improving psychological adjustment among late-stage ovarian cancer patients: examining the role of avoidance in treatment Cogn Behav Pract 19 4 2012 508 517